International Journal of Clinical Pediatric Dentistry · مجلد 19 (6) · 779-793
Background: Dental caries is a common oral health problem that affects people all over the world. To detect and treat it early on, it is important to have a thorough understanding of its genesis and potential biomarkers. Objective: The objective of this systematic review is to answer the question: "Is there any role of immune status in the development of dental caries among children and adults, and is there any potential in using immunological markers for diagnosis, prognosis, and treatment of this condition?" Design: From 2016 to 2024, a thorough search approach adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria was used across several datasets (PROSPERO: CRD42024612045). To find pertinent publications, a total of 2,723 articles were searched using keywords associated with dental caries, immunity, and interventions. The inclusion criteria included papers that addressed the connection between immunity and the development of caries, interventions, and results, including alterations in basal metabolic rate (BMR), weight gain in patients, improvements in quality of life, and recurrence of carious lesions. Two reviewers independently extracted the data, assessed its quality, and assessed the risk of bias using validated instruments such as the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale. Results: The evaluation encompassed 10 articles in all, demonstrating noteworthy correlations between immunological indicators and dental caries. Results point to a favorable correlation between salivary immunoglobulin A (IgA) levels and the number of carious teeth, as well as an increase in proinflammatory cytokine concentrations in dental caries patients. Furthermore, the pulp tissue of dental caries patients has different bacterial communities and higher expression of proinflammatory cytokines, suggesting a possible connection between immune activation and dysbiosis. Conclusion: The findings highlight the significance of immune status/immunological indicators in the diagnosis and treatment of dental caries, emphasizing the necessity for additional study to corroborate these conclusions and improve treatment and preventative dental care practices. Clinical relevance: This work has got great relevance to pediatric dentists. The current work highlights a possible link between the immune status and the development of caries in pediatric and adult patients as well as the potential of immunological markers in the diagnosis, prognosis, and treatment of dental caries in both pediatric and adult patients. Prospero registration number: CRD42024612045.
Frontiers in Cellular and Infection Microbiology · مجلد 16
Correction on: Othman G, A. Badawy A, Hamed Al-Serwi R, El Sayed Zaki M, Tharwat Abou Elkhier N, Alkassaby NM and Saleh Ismail M (2026) Molecular epidemiology of carbapenemaseproducing gram-negative bacilli in diabetic foot infections: association with glycemic control. Front. Cell. Infect. Microbiol. 16:1847743. doi: 10.3389/fcimb.2026.1847743.Grant/funding/project number incorrect An incorrect number was provided for the Deanship of Scientific Research at Northern Border University, Arar, Saudi Arabia. The correct number is NBU-FFR-2026-52-03The original version of this article has been updated.
Frontiers in Cellular and Infection Microbiology · مجلد 16 · 1847743-1847743
Background Carbapenem-resistant Gram-negative bacilli are an increasing threat in diabetic foot ulcer (DFU) infections, limiting therapeutic options and worsening outcomes. However, data linking specific carbapenemase genes to clinical and metabolic factors remain limited. Objectives To isolate Gram-negative bacilli from deep tissue biopsies of DFUs, determine carbapenem susceptibility by minimum inhibitory concentration (MIC) testing, detect major carbapenemase genes by multiplex qPCR, and evaluate their association with glycemic control and Wagner grade. Methods This cross-sectional study included 150 patients with infected DFUs. Isolates recovered from tissue and other specimens were identified by standard microbiological methods, and carbapenem susceptibility was assessed by MIC testing. Multiplex qPCR was used to detect bla KPC, bla NDM, bla OXA-48, bla VIM, and bla IMP, and associations between resistance determinants and clinical variables were analyzed statistically. Results The mean patient age was 56.4 ± 9.8 years, with a male predominance (61.3%), and high-grade ulcers (Wagner III–V) were present in 54.7% of patients. Klebsiella pneumoniae predominated (60.0%), followed by Pseudomonas aeruginosa and Escherichia coli (each 14.7%). Resistance to meropenem and imipenem was high (77.3% and 75.3%, respectively), and carbapenemase production was detected in 84.0% of isolates. bla KPC (28.0%) and bla NDM (24.0%) were the most prevalent genes and were significantly associated with phenotypic carbapenemase production (P = 0.002 and P = 0.006, respectively). Carbapenemase producers showed significantly higher fasting glucose and HbA1c levels than non-producers (P < 0.001), with no significant association observed for Wagner grade (P = 0.570). Conclusions DFUs showed a high burden of carbapenemase-producing Gram-negative bacilli, driven mainly by bla KPC and bla NDM. Poor glycemic control was strongly associated with these resistant infections, underscoring the need for integrated metabolic management, molecular surveillance, and antimicrobial stewardship. These findings position glycemic control as a modifiable driver of antimicrobial resistance in DFUs.
International Journal of Molecular Sciences · مجلد 27 (12) · 5450-5450
Differentiating inflammatory bowel disease (IBD) from diarrhea-predominant irritable bowel syndrome (IBS-D) remains a major clinical challenge due to overlapping symptoms and the limited specificity of single biomarkers. A reliable, non-invasive multimarker approach is needed to improve diagnostic accuracy and reduce unnecessary endoscopic procedures. To evaluate the diagnostic performance of serum interleukin-17A (IL-17A), neutrophil-to-albumin ratio (NAR), and fecal calprotectin (FCP), individually and in combination, for discriminating IBD from IBS-D and healthy controls in Egyptian patients. In this case–control study, 300 participants (100 with IBD, 100 with IBS-D, and 100 healthy controls) were enrolled. Serum IL-17A, NAR, and FCP were measured, and subgroup analysis was performed for infected and non-infected IBS-D patients. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis, with optimal cutoffs determined by the Youden index. A combined biomarker model was constructed using logistic regression. All biomarkers demonstrated a significant stepwise increase from healthy controls to IBS-D and IBD (p < 0.001). IL-17A, NAR, and FCP were elevated in IBS-D compared with controls, indicating low-grade inflammation, but were highest in IBD. No significant differences were observed between infected and non-infected IBS-D patients. Among individual markers, NAR showed the highest diagnostic accuracy (AUC = 0.923), followed by FCP (AUC = 0.884) and IL-17A (AUC = 0.859). The combined model significantly improved performance (AUC = 0.973), achieving 89% sensitivity and 96% specificity. IBS-D is associated with measurable systemic and intestinal inflammation independent of infection status. The combined biomarker model integrating IL-17A, neutrophil–albumin ratio, and fecal calprotectin demonstrated promising discriminatory performance for differentiating IBD from IBS-D. These findings suggest the potential applicability of combined non-invasive biomarkers in future diagnostic stratification approaches. However, the model was developed and evaluated within a single cohort, and external validation in independent populations is required before future potential clinical application. A multimarker diagnostic panel integrating IL-17A, neutrophil–albumin ratio, and fecal calprotectin demonstrated promising diagnostic performance for differentiating inflammatory bowel disease from IBS-D. The combined model may contribute to future diagnostic stratification strategies in patients with chronic diarrhea. However, these findings were derived from a single cohort and require validation in independent populations before broader clinical application.
inflammatory bowel diseasediarrhea-predominant irritable bowel syndromeIL-17Aneutrophil-to-albumin ratio
BACKGROUND: The JAK/STAT signaling pathway plays a crucial role in the release of interferons (IFNs) and the proinflammatory response during SARS-CoV-2 infection, contributing to the cytokine storm characteristic of severe COVID-19 cases. STAT3, a key protein in this pathway, has been implicated in promoting inflammation, making its inhibition a potential therapeutic strategy to mitigate disease severity. Mesenchymal Stem Cell-derived Extracellular Vesicles (MSC-EVs), enriched with immunomodulatory and antiviral miRNAs, offer a promising therapeutic approach by modulating gene expression and regulating inflammatory responses. This study investigates the ability of Lyophilized MSC-EVs to inhibit the JAK/STAT pathway, highlighting their potential application in COVID-19 management. METHODS: Male Syrian hamsters were used as an experimental model, housed under controlled laboratory conditions. SARS-CoV-2 (hCoV-19/Egypt/NRC-03/2020) was propagated in Vero E6 cells, and viral titers were determined using plaque assays. Hamsters were intranasally challenged with the virus and treated intraperitoneally with 0.5 mL of lyophilized human Wharton's jelly-derived MSC-extracellular vesicles (MSC-EVs). Histopathological evaluations were performed on lung tissues using H&E, Masson's trichrome, and immunohistochemical staining. Morphometric analyses were conducted to assess lung injury and fibrosis. Western blotting was employed to evaluate protein expression. All procedures adhered to ethical and biosafety guidelines. RESULTS: The administration of MSC-EVs significantly upregulated the expression levels of miRNA-146a, miRNA-124, miRNA-155, miRNA-29b, miRNA-7, miRNA-145 and miRNA-18a compared to their levels in the COVID-19 group, suggesting a targeted release of miRNA-cargo from the MSC-EVs into the lung tissue of the animals. MSC-EVs impaired the activation of the STAT3/STAT1 signaling pathway and reduced the cytokine storm and coagulopathy associated with COVID-19. CONCLUSIONS: These findings suggest that MSC-EVs have the potential to effectively mitigate the pathogenesis of COVID-19 by targeting the JAK/STAT signaling pathway. Further research is needed to fully understand the mechanisms underlying the therapeutic effects of MSC-EVs and their clinical application in combating the COVID-19 pandemic.
Journal of Radiation Research and Applied Sciences · مجلد 18 (2) · 101537-101537
Objective The H1N1 influenza A virus is the leading cause of seasonal flu outbreaks in humans. Even if there are vaccines for it, it still causes devastating outbreaks and a lot of money to lose. This study aimed to investigate the antiviral efficacy of chitosan nanoparticles and/or propolis against the H1N1 virus. Methods Nanoparticles were synthesized and characterized by transmission electron microscope (TEM). Cytotoxicity was assessed using the MTT assay on Vero cells, and antiviral efficacy was evaluated by calculating the median tissue culture infectious dose (TCID 50 ). Results Chitosan nanoparticles, with average diameters of 100–200 nm were successfully integrated with propolis extract forming rounded aggregates with average diameters ranging between 200 and 300 nm. Remarkably, cytotoxic concentrations against Vero cells for chitosan nanoparticles, propolis extract, and a combination of the two were 277.40 ± 14.94, 238.60 ± 12.25, and 440.10 ± 18.17 μg/mL, respectively. These concentrations indicate high cell viability (>90 %) at doses of 50, 50, and 100 μg/mL, respectively. To evaluate their antiviral effectiveness, the TCID 50 ratios of viral suspensions treated with propolis extract and/or chitosan nanoparticles were compared to those of untreated controls. The results showed that the antiviral activity against the H1N1 influenza A virus improved as the concentration of propolis alone or in the mixture increased, whereas chitosan nanoparticles alone did not exhibit antiviral properties. Conclusions The findings shed light on the possible uses of propolis and chitosan as antiviral drugs against the H1N1 influenza A virus, which are novel, safe, and effective.
Reports of Biochemistry and Molecular Biology · مجلد 14 (2) · 235-249
Background: The current study was designed to examine, whether intermittent fasting can ameliorate the liver damage induced by adriamycin (ADR) in rats, as well as its possible underlying mechanisms. Methods: Forty male Sprague Dawley rats were allocated into 4 equal groups, control, fasting, ADR and ADR+ Fasting groups. At the end of the experiment (eight weeks after ADR administration), blood samples were collected for the measurement of ALT, AST, and albumin, and liver tissues were harvested for biochemical analyses of oxidative stress markers (AMD, GSH and Catalase). Real-time PCR was performed for NRF2 and HO-1, as well as histopathological examination and immunostaining for caspase-3, LC3, and Sirt-1 expression. Results: Administration of ADR caused significant elevation in liver enzymes (ALT, AST), lipid peroxidation (MDA), histopathological damage score and caspase-3 in liver tissues (p< 0.05) with a notable decrease in GSH, catalase, Nrf2, HO-1, LC3, and Sirt-1 genes expression (p< 0.05). Conversely, the application of intermittent fasting (IF) to ADR-treated rats caused significant attenuation of the raised liver enzymes (ALT, AST), lipid peroxidation (MDA), histopathological damage score and caspase-3 in liver tissues and significant improvement in the attenuated GSH, catalase, Nrf2, HO-1, Lc3 and Sirt-1 gene expression (p< 0.05). Conclusions: Intermittent fasting could potentially offer protection against ADR-induced hepatotoxicity in rats by reducing oxidative stress and apoptosis and modifying the expression of Nrf2/HO-1, LC3, and Sirt-1.
BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · 132-147
Background: Artificial Intelligence (AI) in dentistry has the potential to revolutionize oral healthcare by solving its inherent shortcomings. Aim: To review and evaluate the body of research on artificial intelligence's use in dentistry, with a focus on how it affects treatment planning, diagnosis, and patient care in a range of dental specialties. Methodology: 30 papers encompassing oral diagnosis, surgery, endodontics, prosthodontics, orthodontics, forensic dentistry, radiography, and periodontics are thoroughly examined in this review using PRISMA guidelines. The Cochrane Handbook principles were followed in the evaluation of important variables such as randomization, blinding, withdrawal/dropout rates, sample size estimation, clarity of inclusion/exclusion criteria, examiner reliability testing, pre-specification of outcomes, and bias risk. The Newcastle-Ottawa Scale (NOS) was used in quality assessment to measure bias risk and star ratings. Results: The research highlight improvements in diagnosis, treatment planning, and procedural accuracy, illustrating the revolutionary effects of AI in dentistry. Applications of AI demonstrate its versatility and include automated designs, risk prediction, lesion recognition, and precision in dental operations. There is little chance of bias in randomization, intervention variations, and outcome assessments, according to the methodological evaluation, which shows excellent scientific rigor. Even though a few studies had minor issues including uneven blinding and missing data, these had no appreciable impact on the dependability of the results. Overall, the studies' consistent methodological quality highlights how AI may be relied upon to advance dental research and practice.
artificial intelligence in dentistrydental diagnosisdental treatment planningendodontics
Quercetin (QtN) displays low systemic bioavailability caused by poor water solubility and instability. Consequently, it exerts limited anticancer action in vivo. One solution to increase the anticancer efficacy of QtN is the use of appropriate functionalized nanocarriers that preferentially target and deliver the drug to the tumor location. Herein, a direct advanced method was designed to develop water-soluble hyaluronic acid (HA)-QtN-conjugated silver nanoparticles (AgNPs). HA-QtN reduced silver nitrate (AgNO3) while acting as a stabilizing agent to produce AgNPs. Further, HA-QtN#AgNPs served as an anchor for folate/folic acid (FA) conjugated with polyethylene glycol (PEG). The resulting PEG-FA-HA-QtN#AgNPs (further abbreviated as PF/HA-QtN#AgNPs) were characterized both in vitro and ex vivo. Physical characterizations included UV-visible (UV-Vis) spectroscopy, Fourier transform infrared (FTIR) spectroscopy, transmission electron microscopy (TEM), particle size (PS) and zeta potential (ZP) measurements, and biopharmaceutical evaluations. The biopharmaceutical evaluations included analyses of the cytotoxic effects on the HeLa and Caco-2 cancer cell lines using the MTT assay; cellular drug intake into cancer cells using flow cytometry and confocal microscopy; and blood compatibility using an automatic hematology analyzer, a diode array spectrophotometer, and an enzyme-linked immunosorbent assay (ELISA). The prepared hybrid delivery nanosystem was hemocompatible and more oncocytotoxic than the free, pure QtN. Therefore, PF/HA-QtN#AgNPs represent a smart nano-based drug delivery system (NDDS) and could be a promising oncotherapeutic option if the data are validated in vivo.
Saudi Pharmaceutical Journal · مجلد 30 (11) · 1603-1611
This study was performed with the main objective of formulating and evaluating the potential of ethosomesl gel (Etho gel) to deliver nimodipine (NiM) for cardiovascular disease, a potent water insoluble anti-hypertensive drug via skin to reach the deeper layers of skin. The Box-Behnken design (BBD) was used to optimize the NiM-Eth to determine the impact of the independent and depended variables. The effectiveness of drug entrapment, vesicle size, and cumulative drug release were assessed for the NiM loaded ethosomes and NiM-Eth gel using carbopol 934 as a gelling agent. Fourier transform infrared spectroscopy (FTIR), Differential scanning calorimetry (DSC), Power X-ray diffraction (PXRD), and scanning electron microscopy (SEM) analysis were performed and analysed their physicochemical characters. Rat abdomen skin was used to investigate drug permeability and deposition. As compared to marketed products, NiM-Eth gel produced an improved drug permeability in ex vivo experiments. The mean AUC0 to AUC0-∞ of NiM-Eth gel when compared to oral formulation (Nymalize oral preparation) was found to be increased from 4.1 to 5.9 folds which was found to be resulted from first pass effect. Histophatlogical findings revealed that the maximum amount of NiM penetrated the stratum corneum of the skin and create drug depots in the deep layer. In summary, it can be said that NiM might be successfully prepared in NiM-Eth gel for transdermal drug delivery.
nimodipineethosomestransdermal drug deliverypolymer gels